The treatment of chronic progressive multiple sclerosis with cladribine (Q37725229)

22 August 2017

The treatment of chronic progressive multiple sclerosis with cladribine (English)

1 reference

chronic progressive multiple sclerosis

22 August 2017

0 references

1 reference

E Beutler

1

1 reference

22 August 2017

J C Sipe

2

1 reference

22 August 2017

J S Romine

3

1 reference

22 August 2017

J A Koziol

4

1 reference

22 August 2017

R McMillan

5

1 reference

22 August 2017

J Zyroff

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

22 August 2017

5

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

22 August 2017

93

1 reference

22 August 2017

4

1 reference

22 August 2017

1716-1720

1 reference

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Cladribine (2-chlorodeoxyadenosine)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Immunotherapy of multiple sclerosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

New chemotherapeutic agent: 2-chlorodeoxyadenosine.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Multiple sclerosis: a survey of alternative hypotheses concerning aetiology, pathogenesis and predisposing factors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

The efficacy of azathioprine in relapsing-remitting multiple sclerosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Cladribine in treatment of chronic progressive multiple sclerosis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

A distribution-free test for paired growth curve analyses with application to an animal tumour immunotherapy experiment.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=40008

Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden

1 September 2018

1 reference

12 December 2020

Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes

1 reference

12 December 2020

A neurologic rating scale (NRS) for use in multiple sclerosis

1 reference

12 December 2020

Administration of monthly pulses of cyclophosphamide in multiple sclerosis patients. Delayed recovery of several immune parameters following discontinuation of long-term cyclophosphamide treatment

1 reference

12 December 2020

On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration

1 reference

12 December 2020

Marrow suppression produced by repeated doses of cladribine

1 reference

12 December 2020

Cladribine treatment of multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.93.4.1716

1 reference

22 August 2017

0 references

1 reference

22 August 2017

PubMed publication ID

8643695

1 reference